Name: Global Myopia Symposium
Start: 09/09/2022 12:30 AM +00:00
End: 07/09/2023 04:30 PM +00:00

NOTE: The products displayed within this booth are intended for physicians from Singapore and Hong Kong. These products may not be available in your current region. Please email seemyopia@its.jnj.com to learn more.
At Johnson &amp; Johnson Vision, we have a bold ambition: to change the trajectory of eye health worldwide. Serving more than 60 million patients across 103 countries through our operating companies, we deliver innovation that enables eye care professionals to create better outcomes for patients throughout their lives. Since debuting the world&rsquo;s first disposable soft contact lens in 1987, Johnson &amp; Johnson Vision has been helping patients see better through their ACUVUE&reg; Brand Contact Lenses portfolio and by offering products and technologies that address unmet needs including refractive error, cataracts and dry eye. Dual headquartered in Jacksonville, Florida, and Santa Ana, California, we work in collaboration to expand access to quality eye care, and we are committed to helping people see better, connect better and live better. Visit us at www.jjvision.com. Follow @JNJVision on Twitter and Johnson &amp; Johnson Vision on LinkedIn.
Johnson &amp; Johnson Vision is also committed to changing the trajectory of the global myopia epidemic. We&rsquo;re leading with science and evidence, and through a new suite of myopia therapies and resources with the ACUVUE&reg; Abiliti&trade; myopia management portfolio. Visit seeyourabiliti.com to learn more!

Johnson & Johnson Vision

MiSight&reg; 1 day by CooperVision is the FIRST and ONLY FDA-approved dual purpose soft contact lens to correct vision and reduce the rate of myopia progression in children aged 8-12 at the initiation of treatment.*&dagger; &nbsp;It serves as the cornerstone of a comprehensive myopia management approach.
<ul>
<li>Hear more about myopia and MiSight&reg; 1 day on our <a title="MiSight 1 Day YouTube" href="https://www.youtube.com/channel/UCZvRM0yoL-li8ggNUw5yLoA" target="_blank" rel="noopener">YouTube Channel</a></li>
<li>Visit <a title="MiSight 1 Day practitioner site" href="https://coopervision.com/practitioner/our-products/misight-1-day/misight-1-day" target="_blank" rel="noopener">our website</a> for more product information and details for practitioners</li>
<li>Share <a title="MiSight consumer website" href="http://www.misight.com" target="_blank" rel="noopener">MiSight.com</a> with your patients/families to learn more</li>
<li>Register to <a title="Get certified to prescribe MiSight 1 day" href="https://successcenter.coopervision.com/register.php" target="_blank" rel="noopener">get certified</a> to prescribe MiSight&reg; 1 day and start improving the vision and lives of your age appropriate pediatric patients!</li>
</ul>
&nbsp;
*Only FDA approved soft contact lens designed for myopia control in the U.S. &dagger;Indications for use: MiSight 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in chldren with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with &le; 0.75 diopters of astigmatism. The lens is to be discarded after each removal.

MiSight® 1 day

CooperVision Specialty EyeCare represents the bringing together of the knowledge, experience, and bold lineage of the world's leading specialty vision companies&mdash;Blanchard, GP Specialists, Paragon, Procornea, Soflex and No. 7 Contact Lenses&mdash;united for the benefit of today's eye care professionals and the patients they serve.
We embrace the concept that no two eyes, no two patients, and no two days are ever alike. Our team delivers best-in-class service and a wide array of life-changing specialty lenses employed for the successful treatment of myopia management, scleral and advanced contact lens management, and presbyopia management.

CooperVision Specialty EyeCare

EssilorLuxottica is a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. Formed in 2018, its mission is to help people around the world to see more and be more by addressing their evolving vision needs and personal style aspirations. The Company brings together the complementary expertise of two industry pioneers, one in advanced lens technology and the other in the craftsmanship of iconic eyewear, to set new industry standards for vision care and the consumer experience around it. Influential eyewear brands including Ray-Ban and Oakley, lens technology brands including Varilux and Transitions, and world-class retail brands including Sunglass Hut, LensCrafters, Salmoiraghi &amp; Vigan&ograve; and GrandVision are part of the EssilorLuxottica family. EssilorLuxottica has approximately 180,000 employees.

EssilorLuxottica

Euclid is the myopia management partner positioned to take your practice to the next level.
For over 25 years, Euclid has refined the art and science of myopia management with advanced Ortho-K. Each lens is specifically designed for the individual patient&rsquo;s eyes. Thanks to the power of &lsquo;Three Factor Fitting,&rsquo; integrating Euclid Ortho-K into your practice is easy. Simply provide three parameters: RX, K Readings, and HVID, and our unique algorithm does the rest. This efficient, empirical process yields an 87% first fit success*. With the recent launch of MyEuclid&trade;, a cloud-based platform to help drive practice efficiency and optimize your Euclid fits, you can peek behind the curtain to make additional practitioner modifications, easily order and track your lenses, and quickly upload topography to help streamline the fitting process.
Recognized as a world leader, with millions of lenses on eyes, Euclid again leads the way with Euclid MAX&trade; and Euclid MAX Toric. The latest breakthrough in overnight Ortho-K for myopia management, Euclid MAX delivers outstanding material characteristics with proven Euclid designs including a Hyper Dk of 180, the highest of any US overnight Ortho-K brand.
New to Ortho-K or need help getting started? &nbsp;Euclid also offers a step-by-step guide for myopia management implementation including staff training, parent and patient communication, tools, and additional resources.
JUST THREE STEPS TO GET STARTED:
<ol>
<li>Get Euclid certified at https://www.GetEuclidCertified.com (30 minute, FDA-required training)</li>
<li>Schedule a patient exam and record three parameters Rx | K&rsquo;s | HVID</li>
<li>Upload the patient&rsquo;s parameters to MyEuclid&trade; or call (800) 477-9396</li>
</ol>
For more information, email us at sales@euclidsys.com.
*Based on internal data.

Euclid Vision Corporation

Brought to you by PentaVision and Contact Lens Spectrum magazine, the Global Specialty Lens Symposium (GSLS) is the leading global contact lens conference with delegates attending from over 80 countries. With a virtual component in the summer and an in-person meeting in winter, this renowned symposium focuses on the successful management of ocular conditions using today's specialty contact lenses through expert panel discussions, breakout lecture sessions and clinical workshops. Join us again virtually June 15-17, 2023 or sooner in Las Vegas January 18-21, 2023.&nbsp;

Global Specialty Lens Symposium

Contact Lens Spectrum&reg; is the most respected source for clinical contact lens information for optometrists, opticians, and ophthalmologists. Each month, it offers timely editorial on fitting, overcoming complications, utilizing new technologies, gaining patient compliance, and more &mdash; written by contact lens practitioners for contact lens practitioners. In addition, Spectrum shares valuable information via a weekly e-newsletter, Contact Lenses Today.

Contact Lens Spectrum

Optometric Management is dedicated to helping optometrists improve their practice through relevant, actionable, and practical columns and features that enhance patient outcomes and bolster the bottom line. Optometric Management is the leading how-to guide for optometrists interested in growing their practice, improving their standard of care, and achieving financial and professional success.

Optometric Management

Welcome to Day 3 of GMS 2022! <a href="https://events.hubilo.com/global-myopia-symposium/booths">Visit the exhibit hall before the first session begins.</a>&nbsp;

Exhibit Hall Open

The first half of this session will provide detail and discussion on key papers on myopia control, published in the last 12-24 months, which have had a large impact on changing clinical practice. The second half of this session will provide an up-to-the-minute research update from the 2022 International Myopia Conference and how these new findings apply to clinical myopia management.&nbsp;

Nicola Logan, MCOptom, Ph.D., MEd

Pauline Cho, BOptom, MEd, PhD

Kate Gifford PhD, BAppSc(Optom)Hons

Ian Flitcroft, MA D.Phil (oxon) MB BS FRCOphth

Hot Off the Press: Research To Change Your Practice                    

<a href="https://events.hubilo.com/global-myopia-symposium/booths">Last chance to visit the exhibit hall. Don't miss out!</a>&nbsp;

Exhibit Hall Break

This session will be a highly interactive, audience participation session designed to present the delegates with the opportunity to appreciate the importance of full understanding of the numbers relating to the evidence-base of myopia.

Kathryn Richdale, OD, Ph.D.

Elizabeth Lumb

Breakout 6: Myopia Mathletics (Non-CE)

This course aims to familiarize attendees with available options around the world in multifocal lenses for myopia management.&nbsp;

Elise Kramer, OD

Edgar Davila Garcia

Breakout 7: A Global Review of Clinical Applications of Soft Lenses for Myopia Management 

This lecture will review atropine treatment for myopia control with a focus on comparing recent publications to the pioneer studies of myopia progression. In addition, we will explore the potential complications and adverse effects of this treatment and review strategies for improving compliance with treatment.&nbsp;

Global Myopia Symposium

Sessions

Speakers.css-1b24546{margin:0;font-size:1.4rem;font-weight:500;line-height:1.5;color:#7c5c89;font-family:'Poppins',sans-serif;margin-left:0.8rem;}39 Speakers

Pat Caroline

Kevin Chan

Edgar Davila Garcia

Debbie Jones

Randy Kojima

Elise Kramer, OD

Elizabeth Lumb

Thanh Mai

Levent Akduman, MD

Pauline Cho, BOptom, MEd, PhD

Marie-Michele Dupuis, OD, MS

Ian Flitcroft, MA D.Phil (oxon) MB BS FRCOphth

Kate Gifford PhD, BAppSc(Optom)Hons

Charlie L. Ho, OD

Nicola Logan, MCOptom, Ph.D., MEd

Remy Marcotte

John A. McGreal, Jr., OD

Vittorio Mena Jr

Langis Michaud, OD, MS

Jennifer Qayum

Marielle G. Reidy, OD

Dana Reinhardt, OD

Kathryn Richdale, OD, Ph.D.

Patrick Simard

Christina M. Twardowski, OD

Vishakha Thakrar

Ashley D

Jill Woods

Oliver Woo

Debby Yeung, OD, MSc

Thok Chuan Tan

Weizhong Lan

Jeffrey Walline

Shalu Pal, OD

John Gelles, OD

Stephanie Fromstein, OD

Monica Jong, Ph.D., BOptom

Pavan K. Verkicharla, BS Opt, PHD

Justin Kwan, OD, FAAO

Supporters.css-ieqx0d{margin:0;font-size:1.4rem;font-weight:500;line-height:1.5;color:#7c5c89;font-family:'Poppins',sans-serif;color:#ffdaae;margin-left:0.8rem;font-weight:400;}8 Supporters